1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Soft-Tissue Sarcoma: new trials by email Literature Review of Soft-Tissue Sarcoma trials Research Report on Soft-Tissue Sarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS) AL3818, Dacarbazine, AL3818 or placebo - Alveolar Soft Part Sarcoma, Leiomyosarcoma | Phase 3 | Recruiting | Advenchen Laboratories, LLC | 325 | 2017-08-15 | 2026-02-25 |
Leiomyosarcoma (1) · Sarcoma (1) · Sarcoma, Alveolar Soft Part (1) · Sarcoma, Synovial (1)
Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Connective Tissue (1) · Neoplasms, Connective and Soft Tissue (1) · Neoplasms, Muscle Tissue (1)
Dacarbazine (1) · Digoxin (1) · Midazolam (1) · Rosuvastatin Calcium (1) · Tablets (1) · anlotinib (1)
Advenchen Laboratories, LLC (1)
China (1) · Italy (1) · Spain (1) · United Kingdom (1) · United States (1)